Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer Sun Young RhaYong Hwa MoonHyun Cheol Chung Report Pages: 215 - 221
Women with multiple primary breast cancers diagnosed within a five year period, 1994–1998 Holly L. HoweRachel WeinsteinJoellyn H. Ellison OriginalPaper Pages: 223 - 232
Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh Sara RockwellYanfeng LiuSusan A. Higgins OriginalPaper Pages: 233 - 239
Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion Yan-gao ManSidney W. FuPatricia E. Berg OriginalPaper Pages: 241 - 247
Biomarker profile and genetic abnormalities in lobular carcinoma in situ Syed K. MohsinPeter O’ConnellArlene L. Libby OriginalPaper Pages: 249 - 256
Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan Nai-Wen ChangDar-Ren ChenCheng-Shyong Chang OriginalPaper Pages: 257 - 261
Delayed versus immediate exercises following surgery for breast cancer: a systematic review Delva R. ShamleyKaren BarkerAnna Beardshaw OriginalPaper Pages: 263 - 271
Dual role of AP-2γ in ErbB-2-induced mammary tumorigenesis Richard JägerNicolaus FriedrichsHubert Schorle OriginalPaper Pages: 273 - 280
Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A John F. LangenheimWen Y. Chen OriginalPaper Pages: 281 - 293
Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) Kathleen J. YostSusan E. YountDavid Cella OriginalPaper Pages: 295 - 298
Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancer Erika HalapyAnna M. ChiarelliJulia A. Knight OriginalPaper Pages: 299 - 305
Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells Masakazu YashiroKatsumi IkedaKosei Hirakawa OriginalPaper Pages: 307 - 313
Should oral bisphosphonates be standard of care in women with early breast cancer? Mark ClemonsSunil Verma OriginalPaper Pages: 315 - 318
Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer Gianluigi FerrettiMario MandalàFrancesco Cognetti OriginalPaper Pages: 319 - 319
